118 related articles for article (PubMed ID: 31314123)
1. BAP1 Tumour Predisposition Syndrome: A New Mutation in One Family.
Satolli F; de Felici del Giudice MB; Bertolani M; Ricci R; Lotti T; Zucchi A; Feliciani C
Acta Derm Venereol; 2019 Oct; 99(11):1045-1046. PubMed ID: 31314123
[No Abstract] [Full Text] [Related]
2. BAP1 tumor predisposition syndrome case report: pathological and clinical aspects of BAP1-inactivated melanocytic tumors (BIMTs), including dermoscopy and confocal microscopy.
Soares de Sá BC; de Macedo MP; Torrezan GT; Braga JCT; Fidalgo F; Moredo LF; Lellis R; Duprat JP; Carraro DM
BMC Cancer; 2019 Nov; 19(1):1077. PubMed ID: 31706282
[TBL] [Abstract][Full Text] [Related]
3. Clinical and dermoscopic features of cutaneous BAP1-inactivated melanocytic tumors: Results of a multicenter case-control study by the International Dermoscopy Society.
Yélamos O; Navarrete-Dechent C; Marchetti MA; Rogers T; Apalla Z; Bahadoran P; Blázquez-Sánchez N; Busam K; Carrera C; Dusza SW; de la Fouchardière A; Ferrara G; Gerami P; Kittler H; Lallas A; Malvehy J; Millán-Cayetano JF; Nelson KC; Quan VL; Puig S; Stevens H; Thomas L; Marghoob AA
J Am Acad Dermatol; 2019 Jun; 80(6):1585-1593. PubMed ID: 30244062
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.
Walpole S; Pritchard AL; Cebulla CM; Pilarski R; Stautberg M; Davidorf FH; de la Fouchardière A; Cabaret O; Golmard L; Stoppa-Lyonnet D; Garfield E; Njauw CN; Cheung M; Turunen JA; Repo P; Järvinen RS; van Doorn R; Jager MJ; Luyten GPM; Marinkovic M; Chau C; Potrony M; Höiom V; Helgadottir H; Pastorino L; Bruno W; Andreotti V; Dalmasso B; Ciccarese G; Queirolo P; Mastracci L; Wadt K; Kiilgaard JF; Speicher MR; van Poppelen N; Kilic E; Al-Jamal RT; Dianzani I; Betti M; Bergmann C; Santagata S; Dahiya S; Taibjee S; Burke J; Poplawski N; O'Shea SJ; Newton-Bishop J; Adlard J; Adams DJ; Lane AM; Kim I; Klebe S; Racher H; Harbour JW; Nickerson ML; Murali R; Palmer JM; Howlie M; Symmons J; Hamilton H; Warrier S; Glasson W; Johansson P; Robles-Espinoza CD; Ossio R; de Klein A; Puig S; Ghiorzo P; Nielsen M; Kivelä TT; Tsao H; Testa JR; Gerami P; Stern MH; Paillerets BB; Abdel-Rahman MH; Hayward NK
J Natl Cancer Inst; 2018 Dec; 110(12):1328-1341. PubMed ID: 30517737
[TBL] [Abstract][Full Text] [Related]
5. BAP1 Syndrome - Predisposition to Malignant Mesothelioma, Skin and Uveal Melanoma, Renal and Other Cancers.
Foretová L; Navrátilová M; Svoboda M; Házová J; Vašíčková P; Sťahlová EH; Fabian P; Schneiderová M; Macháčková E
Klin Onkol; 2019; 32(Supplementum2):118-122. PubMed ID: 31409087
[TBL] [Abstract][Full Text] [Related]
6. Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases.
Pilarski R; Cebulla CM; Massengill JB; Rai K; Rich T; Strong L; McGillivray B; Asrat MJ; Davidorf FH; Abdel-Rahman MH
Genes Chromosomes Cancer; 2014 Feb; 53(2):177-82. PubMed ID: 24243779
[TBL] [Abstract][Full Text] [Related]
7. Clinical Implications of Real-time Integrative Sequencing in Management of Patients With Suspected Germline BAP1 Mutations.
Sengupta S; Weyand AC; Upadhyaya SA; Wu YM; Robinson DR; Mody RJ
J Pediatr Hematol Oncol; 2019 May; 41(4):e263-e265. PubMed ID: 29554022
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases.
Rai K; Pilarski R; Cebulla CM; Abdel-Rahman MH
Clin Genet; 2016 Mar; 89(3):285-94. PubMed ID: 26096145
[TBL] [Abstract][Full Text] [Related]
9. Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome.
Lalloo F; Kulkarni A; Chau C; Nielsen M; Sheaff M; Steele J; van Doorn R; Wadt K; Hamill M; Torr B; Tischkowitz M; ; Hanson H
Eur J Hum Genet; 2023 Nov; 31(11):1261-1269. PubMed ID: 37607989
[TBL] [Abstract][Full Text] [Related]
10. BAP1 germline mutation in two first grade family members with uveal melanoma.
Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H
Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051
[TBL] [Abstract][Full Text] [Related]
11. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.
Marušić Z; Buljan M; Busam KJ
J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915
[TBL] [Abstract][Full Text] [Related]
12. BAPoma presenting as an incidental scalp papule: case report, literature review, and screening recommendations for BAP1 tumor predisposition syndrome.
Zaayman M; Nguyen P; Silfvast-Kaiser A; Frieder J; West C; Tumminello K; Paek SY
J Dermatolog Treat; 2022 Jun; 33(4):1855-1860. PubMed ID: 34106034
[TBL] [Abstract][Full Text] [Related]
13. BAP1 Germline Mutations in Finnish Patients with Uveal Melanoma.
Turunen JA; Markkinen S; Wilska R; Saarinen S; Raivio V; Täll M; Lehesjoki AE; Kivelä TT
Ophthalmology; 2016 May; 123(5):1112-7. PubMed ID: 26876698
[TBL] [Abstract][Full Text] [Related]
14. Post-thoracotomy neuralgic amyotrophy in a patient with BAP1 tumor predisposition syndrome: Multimodality longitudinal follow-up.
Jazebi N; Dargah-Zada N; Alter K; Shah R; Warga CL; Bond CD; Schrump DS; Lehky T
Muscle Nerve; 2021 Sep; 64(3):E7-E9. PubMed ID: 34050543
[No Abstract] [Full Text] [Related]
15. Prevalence of germline BAP1 mutation in a population-based sample of uveal melanoma cases.
Aoude LG; Vajdic CM; Kricker A; Armstrong B; Hayward NK
Pigment Cell Melanoma Res; 2013 Mar; 26(2):278-9. PubMed ID: 23171164
[No Abstract] [Full Text] [Related]
16. Histologically Diverse BAP1-Deficient Melanocytic Tumors in a Patient With BAP1 Tumor Predisposition Syndrome.
Louw A; Creaney J; Thomas A; Van Vliet C; Harvey NT; Wood BA; Mesbah Ardakani N
Am J Dermatopathol; 2020 Nov; 42(11):872-875. PubMed ID: 32649346
[TBL] [Abstract][Full Text] [Related]
17. Clinical, dermoscopic, histological and molecular analysis of BAP1-inactivated melanocytic naevus/tumour in two familial cases of BAP1 syndrome.
Moawad S; Reigneau M; de la Fouchardière A; Soufir N; Schmutz JL; Granel-Brocard F; Phan A; Bursztejn AC
Br J Dermatol; 2018 Oct; 179(4):973-975. PubMed ID: 29754391
[No Abstract] [Full Text] [Related]
18. The morphologic spectrum of germline-mutated BAP1-inactivated melanocytic tumors includes lesions with conventional nevic melanocytes: A case report and review of literature.
Wysozan TR; Khelifa S; Turchan K; Alomari AK
J Cutan Pathol; 2019 Nov; 46(11):852-857. PubMed ID: 31206729
[TBL] [Abstract][Full Text] [Related]
19. Histomorphologic spectrum of germline-related and sporadic BAP1-inactivated melanocytic tumors.
Garfield EM; Walton KE; Quan VL; VandenBoom T; Zhang B; Kong BY; Isales MC; Panah E; Kim G; Gerami P
J Am Acad Dermatol; 2018 Sep; 79(3):525-534. PubMed ID: 29753057
[TBL] [Abstract][Full Text] [Related]
20. Population-based analysis of BAP1 germline variations in patients with uveal melanoma.
Repo P; Järvinen RS; Jäntti JE; Markkinen S; Täll M; Raivio V; Turunen JA; Kivelä TT
Hum Mol Genet; 2019 Jul; 28(14):2415-2426. PubMed ID: 31058963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
